laboratory reagents - rapid tests - infectious diseases - Coronavirus (SARS-CoV-2) Antigen + Influenza A&B Antigen - Combo - Nasopharyngeal / Nasal / Oropharyngeal swab, for professional use, Performance characteristics: sensitivity: 97,06% - SARS-CoV-2, 90,48% - Influenza A, 88,89% - Influenza B; specificity: 99,68% - SARS-CoV-2, 99,42% - Influenza A, 99,44% - Influenza B; accuracy: 99,32% - SARS-CoV-2, 98,91% - Influenza A, 99,18% - Influenza B, versus the RT-PCR method, 25 sets/kit: cassette + sterile nasopharyngeal / nasal / oropharyngeal swab + tube + tip + buffer, CE mark, code VLD01-03-13-011
ISO 
